Position in IMVT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$18,190,858
+$1,186,612 QoQ
Shares Held
472,122
-31.0% QoQ
Ownership
0.229%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 226 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Derivatives in IMVT
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$384,000
PutShares
24,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. IMVT ranks #86 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in IMVT
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,190,858 | 472,122 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $17,004,246 | 684,551 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $18,617,251 | 732,386 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $11,705,908 | 726,173 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $384,000 | 24,000 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $10,740,544 | 671,284 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,507,367 | 731,853 | Shares | Defined | 2025-05-13 | |
| 2025-03-31 | $410,160 | 24,000 | Put | Defined | 2025-05-13 | |
| 2024-12-31 | $14,633,222 | 590,764 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $594,480 | 24,000 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $684,240 | 24,000 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $4,019,595 | 140,989 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $633,600 | 24,000 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $3,150,970 | 119,355 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,544,389 | 202,550 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,533,604 | 155,082 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $3,255,356 | 84,797 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,744,006 | 91,935 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,908,287 | 123,036 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,731,281 | 153,875 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $38,937 | 6,978 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $8,903 | 2,283 | Shares | Defined | 2022-08-10 | |
| 2021-12-31 | $1,418,869 | 166,534 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $423,532 | 48,738 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $387,316 | 36,643 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,333,405 | 83,130 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,274,164 | 49,235 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $29,524 | 839 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $169,354 | 6,955 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $36,686 | 2,357 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||